During the past decade, Mark Lamet, M.D. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mark Lamet, M.D." are "Ulcerative Colitis" (3 trials), "Inflammatory Bowel Disease" (2 trials), "Crohn's Disease" (1 trials) and "Diverticulitis" (1 trials). Many other conditions were trialed in "Mark Lamet, M.D." in a lesser frequency.

Most popular intervention types in "Mark Lamet, M.D." are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "5 ASA, enemas, suppositories, corticosteroids" (1 trials), "Adalimumab" (1 trials), "Balsalazide Disodium" (1 trials), "Balsalazide disodium" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mark Lamet, M.D." are 5 trials for "All" genders.

Currently, there are NaN active trials in "Mark Lamet, M.D.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mark Lamet, M.D., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mark Lamet, M.D., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".